BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.
New Test Immediately Available to Increase Capacity of Rapid, On-Site Testing of COVID-19 at Hospitals Across the U.S.Apr 3, 2020 FRANKLIN LAKES, N.J. and BIRMINGHAM, Ala. April 3, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc., a molecular diagnostics company, today announced that the U.S.... Read more